Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jun;10(6):2840-7.
doi: 10.1128/mcb.10.6.2840-2847.1990.

Oncogenic transformation by vrel requires an amino-terminal activation domain

Affiliations

Oncogenic transformation by vrel requires an amino-terminal activation domain

J Kamens et al. Mol Cell Biol. 1990 Jun.

Abstract

The mechanism by which the products of the v-rel oncogene, the corresponding c-rel proto-oncogene, and the related dorsal gene of Drosophila melanogaster exert their effects is not clear. Here we show that the v-rel, chicken c-rel, and dorsal proteins activated gene expression when fused to LexA sequences and bound to DNA upstream of target genes in Saccharomyces cerevisiae. We have defined two distinct activation regions in the c-rel protein. Region I, located in the amino-terminal half of rel and dorsal proteins, contains no stretches of glutamines, prolines, or acidic amino acids and therefore may be a novel activation domain. Lesions in the v-rel protein that diminished or abolished oncogenic transformation of avian spleen cells correspondingly affected transcription activation by region I. Region II, located in the carboxy terminus of the c-rel protein, is highly acidic. Region II is not present in the v-rel protein or in a transforming mutant derivative of the c-rel protein. Our results show that the oncogenicity of Rel proteins requires activation region I and suggest that the biological function of rel and dorsal proteins depends on transcription activation by this region.

PubMed Disclaimer

References

    1. J Virol. 1988 Dec;62(12):4730-6 - PubMed
    1. Cell. 1988 Nov 4;55(3):487-95 - PubMed
    1. Nature. 1989 Feb 16;337(6208):666-8 - PubMed
    1. Nature. 1989 Mar 2;338(6210):39-44 - PubMed
    1. Oncogene Res. 1989;4(1):1-8 - PubMed

Publication types

Substances

LinkOut - more resources